EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Prognostic significance of nutritional and muscular indices in immune checkpoint inhibitor therapy for metastatic urothelial carcinoma: A preliminary study

Satoshi Yamamoto, Keita Higa, Koichiro Kurokawa, Hiroki Bamba, Sanji Kanaoka, Kazuyoshi Nakamura

Nutrition · 2026

DOI: 10.1016/j.nut.2025.113028 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Nutrition, 2026. Verfasst von Satoshi Yamamoto und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Kimitsu Chuo Byoin, Kisarazu City, Chiba, Japan. Electronic address: satoshi.ym0809@gmail.com. Hauptthemen laut MEDLINE: Carcinoma, Transitional Cell, Urologic Neoplasms, Immune Checkpoint Inhibitors, Antineoplastic Agents, Immunological. Die Arbeit nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: The shift from chemotherapy to immune checkpoint inhibitors (ICIs) for metastatic urothelial carcinoma (UC) highlights the need for effective prognostic markers. Since traditional markers have limitations, we investigated whether the easily accessible psoas muscle index (PMI) and prognostic nutritional index (PNI) could predict treatment outcomes. METHODS: This retrospective study involved 55 metastatic UC patients. All patients initially received platinum-based chemotherapy before starting ICI therapy with pembrolizumab or avelumab. We calculated baseline PMI from CT scans at the L3 vertebral level and PNI from serum albumin and lymphocyte counts. A multivariate Cox proportional hazards regression model was used to identify independent prognostic factors for overall survival (OS). RESULTS: Multivariate analysis showed that PMI (HR = 0.72, 95% CI: 0.51-0.99, P = 0.044), liver metastasis (HR = 10.6, 95% CI: 1.78-63.6, P = 0.010), and PNI (HR = 0.84, 95% CI: 0.71-0.97, P = 0.022) were significant, independent prognostic factors for OS. The results of the multivariate analysis are unadjusted for potential confounding factors and should be interpreted with caution. When we stratified patients into high- and low-risk groups based on these three factors, there was a statistically significant difference in OS between the groups (log-rank test, P < 0.001). CONCLUSION: PMI and PNI are valuable, independent prognostic markers for metastatic UC patients. They could serve as practical prognostic markers to guide personalized treatment strategies, such as more intensive therapies or nutritional support for high-risk patients. Future large-scale studies are necessary to validate these results and establish standardized cutoff values.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Transitional CellUrologic NeoplasmsImmune Checkpoint InhibitorsAntineoplastic Agents, ImmunologicalHealth Status IndicatorsRetrospective StudiesPrognosisNutrition AssessmentFunctional StatusUrotheliumNutritional StatusTreatment OutcomeNeoplasm MetastasisPsoas MusclesPredictive Value of TestsHumansMaleFemaleAdultMiddle AgedAgedAged, 80 and overProportional Hazards ModelsAntibodies, Monoclonal, Humanized

Stichwörter der Autor:innen

Immune checkpoint inhibitorPractical prognostic markersPrognostic nutritional indexPsoas muscle indexUrothelial carcinoma

Substanzen

Immune Checkpoint InhibitorspembrolizumabavelumabAntineoplastic Agents, ImmunologicalAntibodies, Monoclonal, Humanized

Autor:innen und Institutionen

  • Department of Urology, Kimitsu Chuo Byoin, Kisarazu City, Chiba, Japan. Electronic address: satoshi.ym0809@gmail.com.
  • Department of Urology, Kimitsu Chuo Byoin, Kisarazu City, Chiba, Japan.

Zitieren

APA

Yamamoto, S., Higa, K., Kurokawa, K., Bamba, H., Kanaoka, S., & Nakamura, K. (2026). Prognostic significance of nutritional and muscular indices in immune checkpoint inhibitor therapy for metastatic urothelial carcinoma: A preliminary study. Nutrition. https://doi.org/10.1016/j.nut.2025.113028

Vancouver

Yamamoto S, Higa K, Kurokawa K, Bamba H, Kanaoka S, Nakamura K. Prognostic significance of nutritional and muscular indices in immune checkpoint inhibitor therapy for metastatic urothelial carcinoma: A preliminary study. Nutrition. 2026. doi:10.1016/j.nut.2025.113028

BibTeX
@article{Yamamoto2026,
  author = {Yamamoto, Satoshi and Higa, Keita and Kurokawa, Koichiro and Bamba, Hiroki and Kanaoka, Sanji and Nakamura, Kazuyoshi},
  title = {Prognostic significance of nutritional and muscular indices in immune checkpoint inhibitor therapy for metastatic urothelial carcinoma: A preliminary study},
  journal = {Nutrition},
  year = {2026},
  doi = {10.1016/j.nut.2025.113028}
}
Kostenlos starten →